MXPA06003872A - Inhalador de polvo seco. - Google Patents

Inhalador de polvo seco.

Info

Publication number
MXPA06003872A
MXPA06003872A MXPA06003872A MXPA06003872A MXPA06003872A MX PA06003872 A MXPA06003872 A MX PA06003872A MX PA06003872 A MXPA06003872 A MX PA06003872A MX PA06003872 A MXPA06003872 A MX PA06003872A MX PA06003872 A MXPA06003872 A MX PA06003872A
Authority
MX
Mexico
Prior art keywords
inhaler
formoterol
process according
pressure
dry powder
Prior art date
Application number
MXPA06003872A
Other languages
English (en)
Spanish (es)
Inventor
Magnus Olsson
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of MXPA06003872A publication Critical patent/MXPA06003872A/es

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
    • B65B31/00—Packaging articles or materials under special atmospheric or gaseous conditions; Adding propellants to aerosol containers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00—Inhalators
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C71/00—After-treatment of articles without altering their shape; Apparatus therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/06—Solids
    • A61M2202/064—Powder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/02—General characteristics of the apparatus characterised by a particular materials
    • A61M2205/0233—Conductive materials, e.g. antistatic coatings for spark prevention
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C2791/00—Shaping characteristics in general
    • B29C2791/004—Shaping under special conditions
    • B29C2791/006—Using vacuum
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29L—INDEXING SCHEME ASSOCIATED WITH SUBCLASS B29C, RELATING TO PARTICULAR ARTICLES
    • B29L2031/00—Other particular articles
    • B29L2031/753—Medical equipment; Accessories therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mechanical Engineering (AREA)
  • Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
MXPA06003872A 2003-10-07 2004-10-04 Inhalador de polvo seco. MXPA06003872A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0302665A SE0302665D0 (sv) 2003-10-07 2003-10-07 Novel Process
PCT/GB2004/004202 WO2005035036A1 (en) 2003-10-07 2004-10-04 Dry powder inhaler

Publications (1)

Publication Number Publication Date
MXPA06003872A true MXPA06003872A (es) 2006-07-03

Family

ID=29398687

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA06003872A MXPA06003872A (es) 2003-10-07 2004-10-04 Inhalador de polvo seco.

Country Status (15)

Country Link
US (2) US7896005B2 (https=)
EP (1) EP1680163A1 (https=)
JP (1) JP4589928B2 (https=)
KR (1) KR101110444B1 (https=)
CN (2) CN101856532A (https=)
AU (1) AU2004280109B2 (https=)
BR (1) BRPI0415189A (https=)
CA (1) CA2541374C (https=)
IL (1) IL174735A (https=)
MX (1) MXPA06003872A (https=)
NO (1) NO336190B1 (https=)
NZ (1) NZ546405A (https=)
SE (1) SE0302665D0 (https=)
WO (1) WO2005035036A1 (https=)
ZA (1) ZA200602831B (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1015883A3 (fr) * 2004-06-08 2005-10-04 Occhio Procede et dispositif de dispersion de poudres seches.
US8546423B2 (en) 2005-05-18 2013-10-01 Mpex Pharmaceuticals, Inc. Aerosolized fluoroquinolones and uses thereof
EP2346509B1 (en) 2008-10-07 2020-05-13 Horizon Orphan LLC Inhalation of levofloxacin for reducing lung inflammation
JP2012505223A (ja) 2008-10-07 2012-03-01 エムペックス・ファーマシューティカルズ・インコーポレーテッド 薬物動態の改善のためのエアゾールフルオロキノロン配合物
GB0912373D0 (en) 2009-07-16 2009-08-26 Innovata Biomed Ltd Improvements in or relating to dry powder inhalers
RU2563809C2 (ru) 2009-09-04 2015-09-20 Мпекс Фармасьютикалс, Инк. Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза
GB201118188D0 (en) * 2011-10-21 2011-12-07 3M Innovative Properties Co Manufacture of medicinal aerosol canisters
US11052202B2 (en) * 2012-11-07 2021-07-06 Chiesi Farmaceutici S.P.A. Drug delivery device for the treatment of patients with respiratory diseases
PL3789066T3 (pl) * 2014-03-03 2023-03-20 Adherium (Nz) Limited Monitor prawidłowości podawania leku do urządzenia dostarczającego suchy sproszkowany lek
NO2709641T3 (https=) 2014-03-10 2018-05-12
AR106018A1 (es) 2015-08-26 2017-12-06 Achillion Pharmaceuticals Inc Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos
WO2017035408A1 (en) 2015-08-26 2017-03-02 Achillion Pharmaceuticals, Inc. Compounds for treatment of immune and inflammatory disorders
RU2018145364A (ru) 2016-06-27 2020-07-28 Ачиллион Фармасьютикалс, Инк. Хиназолиновые и индольные соединения для лечения медицинских нарушений
CN110603252A (zh) 2017-03-01 2019-12-20 艾其林医药公司 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物
CN108771761B (zh) * 2018-08-16 2021-12-14 上海方予健康医药科技有限公司 一种糖皮质激素与β2受体激动剂的复方干粉吸入剂的制备工艺
WO2020041301A1 (en) 2018-08-20 2020-02-27 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement factor d medical disorders
EP3866773B1 (en) 2018-10-16 2024-08-28 Georgia State University Research Foundation, Inc. Carbon monoxide prodrugs for the treatment of medical disorders
CN119837855A (zh) 2019-12-19 2025-04-18 乔治亚州大学研究基金会 用于治疗细菌感染和增强抗生素的化合物
WO2021168320A1 (en) 2020-02-20 2021-08-26 Achillion Pharmaceuticals, Inc. Heteroaryl compounds for treatment of complement factor d mediated disorders
USD949321S1 (en) * 2020-05-29 2022-04-19 NuvoAir AB Housing for an add-on sensor for an inhaler
WO2022066774A1 (en) 2020-09-23 2022-03-31 Achillion Pharmaceuticals, Inc. Pharmaceutical compounds for the treatment of complement mediated disorders

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3274065D1 (de) * 1981-07-08 1986-12-11 Draco Ab Powder inhalator
SE9400257D0 (sv) * 1994-01-27 1994-01-27 Astra Ab Spacer
SE9400570D0 (sv) 1994-02-21 1994-02-21 Astra Ab Inhalation device, inhaler and processing unit
US6390291B1 (en) * 1998-12-18 2002-05-21 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
US6119853A (en) * 1998-12-18 2000-09-19 Glaxo Wellcome Inc. Method and package for storing a pressurized container containing a drug
US6315112B1 (en) * 1998-12-18 2001-11-13 Smithkline Beecham Corporation Method and package for storing a pressurized container containing a drug
GB2353222B (en) 1999-06-23 2001-09-19 Cambridge Consultants Inhalers
GB0107106D0 (en) 2001-03-21 2001-05-09 Boehringer Ingelheim Pharma Powder inhaler formulations
WO2003035028A1 (en) 2001-10-19 2003-05-01 Nektar Therapeutics Modulating charge density to produce improvements in the characteristics of spray-dried proteins
GB0130857D0 (en) * 2001-12-22 2002-02-06 Glaxo Group Ltd Medicament dispenser

Also Published As

Publication number Publication date
US8205611B2 (en) 2012-06-26
IL174735A (en) 2010-12-30
KR20060115728A (ko) 2006-11-09
IL174735A0 (en) 2006-08-20
CN101856532A (zh) 2010-10-13
SE0302665D0 (sv) 2003-10-07
BRPI0415189A (pt) 2006-11-28
JP2007507270A (ja) 2007-03-29
AU2004280109A1 (en) 2005-04-21
ZA200602831B (en) 2007-07-25
EP1680163A1 (en) 2006-07-19
KR101110444B1 (ko) 2012-02-17
US20110056089A1 (en) 2011-03-10
JP4589928B2 (ja) 2010-12-01
CA2541374A1 (en) 2005-04-21
US7896005B2 (en) 2011-03-01
WO2005035036A1 (en) 2005-04-21
NZ546405A (en) 2008-11-28
NO336190B1 (no) 2015-06-08
US20070107721A1 (en) 2007-05-17
CN1889991B (zh) 2010-09-08
AU2004280109B2 (en) 2008-05-22
NO20062065L (no) 2006-06-29
CA2541374C (en) 2013-05-14
CN1889991A (zh) 2007-01-03

Similar Documents

Publication Publication Date Title
US8205611B2 (en) Dry powder inhaler
AU2001282743B2 (en) Electro-powder
CA2115065C (en) Ultrafine particle powder for inhalation and method for production thereof
EP0750492B1 (en) Inhalation composition containing lactose pellets
US20190216731A1 (en) Process for providing particles with reduced electrostatic charges
CN1805731B (zh) 用于提高剂量效率的药物组合物和装置
KR100496836B1 (ko) 알부테롤용정량흡입기
EP2043717A1 (en) Inhalation system and delivery device for the administration of a drug in the form of dry powder
CN1186473A (zh) 二丙酸氯地米松计定剂量吸入器
JPH08507704A (ja) 吸入装置
JP2002506696A (ja) エーロゾル容器用バルブ
AU2001282743A1 (en) Electro-powder
JP2006511257A (ja) 医薬送達用システムに使用するための管状ノズル
JP2007507270A5 (https=)
WO2020198051A1 (en) Inhalable dry powders
WO2003053406A1 (en) Fluorinated particles for inhalation & pharmaceutical formulation

Legal Events

Date Code Title Description
FG Grant or registration